| Questions And Answer | Back Directory | [Description]
Glofitamab is part of Genentech's industry-leading CD20xCD3 bispecific antibody development program, which aims to address the diverse needs and preferences of people with blood cancers. | [Uses]
Glofitamab is a T-cell binding bispecific antibody designed to target CD20 on the surface of B cells and CD3 on the surface of T cells. |
|
| Company Name: |
Biolab Reagents
|
| Telephone: |
027-65279366 18108604356 |
| Website: |
www.biolabreagent.com/ |
|